September 2005
Fighting against the 'other' billboard attacks
by Dr. Terry A. Rondberg
Last month, The
Chiropractic Journal ran the news story about the billboard in
Connecticut that blared the warning: "Chiropractic Adjustments Can Kill or
Permanently Disable You." We were all proud of the many DCs who took
immediate action to force the billboard company to cover up the display.
It's obvious that doctors are willing to stand up and do something when they
see their profession under attack like this.
But what about the
attacks that are less blatant but just as damaging? What are we doing about
the "billboards" that say things like:
"There is no
scientific evidence that adjustments to bones or vertebrae will correct
specific conditions such as asthma, bronchitis, kidney disease or
constipation." ("What Chiropractors Can‑And Can't‑Do for You," Tufts
University Health & Nutrition Letter, February, 2003)
or this ...
"There is a lack of
sufficient evidence to support many of the claims of efficacy (of
chiropractic and other alternative health care approaches)." (British
Medical Association)
or this ...
"There is no solid
scientific evidence for subluxations." ("Chiropractic: A 100 year struggle
from pseudoscience to legitimacy," by Mahlon Wagner, PhD)
or this ...
"There is no
scientific evidence whatsoever that the so‑called chiropractic spinal
adjustment results in any correction to a child's spine. These adjustments
are ineffective and useless." (NCAHF Fact Sheet on Chiropractic) ?
I've seen dozens of
these kinds of statements in newspapers, magazines and newsletters
distributed to millions of people around the world. They're repeated on
hundreds of websites throughout the Internet. More people will read these
warnings in a single day than the New Jersey sign would have reached in a
year.
Why,
then, aren't we doing something about these other "billboards" that are
scaring off our patients?
The biggest reason is
that we don't have the right ammunition to fight back. We can't claim the
statements are lies or slander. After all, truth is a defense against
slander and our accusers need only look us in the eye and say "show me the
research."
And the fact is, we
don't have the kind of research we need to shut them up.
I'm not the only one
who thinks this way. Just about every chiropractic researcher agrees that we
have a tremendous "dearth of good research to prove efficacy," as
Newsweek magazine so bluntly put it.
William Meeker, DC,
director of the Palmer Center for Chiropractic Research, stated: "Let's face
it. We have a massive fact deficit in chiropractic. I fear the profession
still doesn't realize it, or how dangerous it is to our future.... the time
has come to reassess our professional commitment, our strategies, and our
priorities for the science of chiropractic." He said that in a 1996
article in Dynamic Chiropractic.
Here we are, nearly a
decade later, and there's been little progress. The World Federation of
Chiropractic noted during its Identity Consultation this summer, "There is
little existing research or scientific evidence to support chiropractic's
role in overall health improvement."
During those
intervening years, we heard the message repeated many times.
In 1999, the Journal
of the American Chiropractic Association (JACA) ran a report by Dr.
Cheryl Hawk, an associate professor at the Palmer
Center for Chiropractic Research at
Palmer College of Chiropractic and this year's Foundation for Chiropractic
Education and Research (FCER) "Researcher of the Year." She stated that
without research on clinical and economic outcomes, chiropractic will not
prosper. "If we could get evidence for what we do, we could definitely treat
many more types of problems and many more types of patients in years to
come," she said.
In a 2002 JACA
article, Ronald J. Feise, the president and a faculty member of the
Institute of Evidence‑Based Chiropractic and research director of the
American Chiropractic Scoliosis Foundation, noted: "Although the importance
of chiropractic research in professional practice is widely accepted, and
using research to guide chiropractic practice has been a long‑standing goal
of the profession, the actual integration of research into practice is not
yet widespread. This lack of research utilization is threatening the
integrity of the profession."
With all due respect to
those researchers who are working hard to produce evidence of chiropractic's
efficacy and safety ‑‑ and they're producing some excellent work ‑‑ it's not
enough. We aren't compiling the kind of irrefutable data using large scale
population studies that will convince our critics and the public. We're
still focusing too much on back pain relief studies and failing to use
modern public relations methods to interpret the findings so that laypeople
can understand them.
The profession also
hasn't responded to the continual pleas for financial support for research
efforts.
In the Spring/Summer
2005 issue of the FCER publication Advance, Dr. Meeker complained,
"there are not many more people doing chiropractic research now than there
were 10 years ago." He admitted that, in a way, his article was an
"indictment of this profession's inability to grow its research
enterprises... We can't even find jobs for promising young scientists in our
institutions. Only a small number of grant applications are submitted to the
National Institutes of Health, even though manipulation research is
explicitly on their scientific agenda. Our peer‑reviewed scientific journals
are in chronic financial trouble."
He warned that "our
profession's research capacity must take a significant leap forward, and all
chiropractors must understand and apply the fruits of scientific evidence,"
but added, "It takes people with curiosity, knowledge, skills, motivation,
time, and lots and lots of money."
Well, Dr. Meeker is no
doubt relieved and pleased to read about the introduction of RCS ‑‑ Research
& Clinical Science ‑‑ a private sector research company that is filled with
people with just those attributes. RCS is embarking on what will be the
largest outcomes research project ever conducted in chiropractic, and
possibly in medicine. It will definitely "grow" chiropractic's research
enterprises, help turn the profession into an army of clinical
investigators, make it easier to receive grant funding, and spur a renewed
interest in chiropractic research within the profession itself.
Most critically, it
will compile subjective and objective data on hundreds of thousands of
people around the globe, analyze and correlate that data, and identify
specific chiropractic outcomes. It will provide the scientific evidence that
chiropractic can be used to address a variety of health issues and improve
general wellness levels.
To do that, RCS has
developed its research protocol so meticulously that it will be impossible
for critics to refute or ignore the results.
For example, the
program itself and all of its principle investigators have undergone
rigorous examination by an independent Institutional Review Board (IRB), a
federal requirement for all human subject studies. Every detail of the
program ‑‑ including the way in which volunteers are recruited, the data
collection process, the integrity and security of the database, and even the
financial arrangements between RCS and its investigators ‑‑ was carefully
scrutinized and approved.
In addition, every
doctor of chiropractic who becomes an RCS Authorized Clinical Investigator,
must go through that same process and become an IRB‑approved researcher.
Every legitimate researcher whose investigations involve interaction with
human subjects must have this approval and very few doctors of chiropractic
outside academia have ever received it.
Yet, RCS will have
hundreds of IRB‑approved chiropractors working from their offices,
collecting data on volunteers and existing patients. These RCS doctors will
also have to complete an online training course by the National Institutes
of Health and a two‑day training session held by RCS on the campus of the
University of California‑Irvine.
They'll emerge having earned a Fellowship in Health Outcomes Research.
Every RCS doctor is to
be carefully monitored by RCS, which was founded by David Jackson, DC, past
president of the Chiropractic Leadership Alliance and Creating Wellness
Alliance; Matthew McCoy, DC, director of the Office of Sponsored Research
and Scholarly Activities at Life University's College of Chiropractic, and
editor of the Journal of Vertebral Subluxation Research; and Robert
Blanks, PhD, professor in the Department of Biomedical Sciences at Florida
Atlantic University and a past professor of anatomy and neurobiology at the
University of California‑Irvine.
They'll be required to
use only those volunteer recruitment methods and materials developed by RCS
following guidelines based on those of the Mayo Clinic, the Naval
Medical Research Center, the
University of Maryland School of Medicine, Massachusetts General Hospital
and the University of Kentucky Chandler Medical Center. The wording and even
the design of the ads and flyers were approved by the IRB. Doctors will also
use informed consent forms written by the IRB itself, in order to fully
protect all volunteers.
RCS Authorized Clinical
Investigators will also be regulated as to how they handle volunteers who
choose to become patients. Volunteers will be clearly informed of which
services (such as the initial examination, data collection, and Vitality
Wellness Index report) are provided free of charge and which (such as actual
chiropractic care) are not part of the research program.
In this, RCS has again
adopted guidelines similar to medical research institutions. The Mayo
Clinic, for example, tells volunteers:
"You and/or your health
plan will need to pay for all tests and procedures that are part of this
study because they are needed for your regular medical care. The study drug
will be given to you at no cost. However, you may need to pay for the
preparing of the study drug. You or your health plan might also have to pay
for other drugs or treatments which are given to help you control side
effects. Before you take part in this study, you should call your health
insurer to find out if the cost of these tests and/or procedures will be
paid for by the plan. Some health insurers will not pay for these costs. You
will have to pay for any costs not covered by your health insurer."
The Kansas City
Clinical Oncology Program has similar policies. It informs volunteers that
"... medical care costs including laboratory tests, radiology procedures,
and medications that are specifically required prior to and during this
clinical research study shall be your responsibility unless specified. You
have been given the opportunity to discuss the expenses or costs associated
with your participation in this research activity.... As part of the
evaluation of this treatment, you will be asked to regularly submit blood
samples and undergo regular physical examination and x‑ray studies. Almost
all of these studies are routinely obtained as part of the general follow‑up
and surveillance of patients, and are not part of the investigational aspect
of this study.... You and/or your health plan will need to pay for all costs
associated with administration of this treatment. The blood drawn for
research purposes will be done at the same time as the blood draws needed
for your regular medical care. Baseline MUGA scan/echocardiogram will be
paid for by you or your health plan as these are clinically indicated tests
when receiving AC treatment. ... You or your health plan might also have to
pay for other drugs or treatments that are given to help you control side
effects."
The University of
Michigan Medical Center's General Clinical Research Center, one of 79 NIH‑funded
clinical research centers at leading hospitals throughout the United States,
includes this statement on its informed consent form:
"If the subject is
receiving care for a condition or illness, and is seen in a protocol that
involves an accepted form of treatment, either the patient, or the insurance
company representing that patient, is responsible for the costs of that
medical care. The NIH grant pays for only those tests and procedures
performed for research purposes; room charges and standard treatment costs
are charged to the participant's insurance."
The Bryanlgh Medical
Center Saint Elizabeth Regional Medical Center's consent form for its "Phase
I/II Trial Of Pyrazoloacridine And Carboplatin In Patients With Recurrent
Gliomas (Study 3) noted:
"You understand you are
responsible for all expenses incurred during your hospitalization including
supply costs (e.g., IV solutions) and preparation costs for preparing your
treatment. You will not be billed for any investigational agents provided at
no charge to the hospital.
"The Division of Cancer
Treatment and Diagnosis of the National Cancer Institute will give the PZA
free of charge for this study. Should
PZA
become commercially available during the course of the study, however, you
may be asked to buy the remaining doses of the medicine.
"... Other costs such
as pharmacy charges, the cost to administer the drugs, and the use of
medications or other types of treatment to help control side effects could
result in added costs to you and/or your health plan. You and/or your health
plan will need to pay for all tests and procedures that are part of this
study because they are needed for your regular medical care. Before you take
part in this study, you should call your health insurer to find out if the
cost of these tests and/or procedures will be paid for by the plan. Some
health insurers will not pay for these costs. .. You will have to pay for
any costs not covered by your health insurer."
RCS doctors will be
free to choose whether they wish to accept these volunteers as patients or
refer them to other practitioners.
Most impressive of all
is the caliber of the RCS International Scientific Advisory Panel, made up
of world‑class researchers including: Margaret V. Ames, PhD, a nationally
recognized expert in health promotion as well as disease prevention
communication activities who serves in federal government health department;
Yoshimi Shibata, PhD, associate professor, Department of Biomedical
Sciences, Charles E. Schmidt College of Science, Florida Atlantic
University; Isaac Ogwel Opole, MD, PhD, resident, Department of Internal
Medicine, Kansas University Medical Center; and James Fallon, PhD,
professor, Department of Anatomy & Neurobiology, University of
California‑Irvine, College of Medicine. (To learn more about the Panel,
visit the RCS website at www.rcsprogram.com).
When this group of
scientists begins putting together the scientific papers that will be
submitted to major peer‑reviewed medical and chiropractic journals, the
world will sit up and take notice!
Realizing it was time
to try something new and innovative, to take research out of the ivory tower
realm and into chiropractic offices, RCS managed to solve the problem of
chronic under‑funding of chiropractic research ‑‑ by eliminating the need to
rely on (and continuously beg for) donations from the profession. In making
research a private enterprise and giving the doctors enough benefits to make
it well worth their while to pay to become an RCS Authorized Clinical
Investigator, RCS has put chiropractic research on the same playing field as
medical research, which is conducted in great part by businesses such as
drug companies.
Actually, it's more
than innovative. It's revolutionary. But it will take a revolution to beat
back our profession's critics as they continue to label chiropractic
"unscientific" in order to keep us subservient to the medical and drug
industries. And I can't think of any company or group better qualified to
lead this revolution than RCS.
If you'd like to get a
packet of information that tells you more about RCS and the research it's
conducting, you can call 800‑909‑1354 or 480‑303‑1694, or visit the RCS
website at www.rcsprogram.com. Doctors of chiropractic may log on to a
special limited‑access area of the site by using the username TRguest and
password RESEARCH.